Physician profile
Benjamin William Brewer
NPI 1235997784
$919.43
in general payments reported to CMS, 2019-2025
16 companies · $669 in 2025
The $669 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $250 · 2025: $669.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $919.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $919.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calliditas Therapeutics US INC. | $209.38 | 2025 | Tarpeyo |
| Medtronic, INC. | $165.43 | 2025 | Symplicity G3 |
| Cormedix INC. | $140.65 | 2024-2025 | Defencath, Defencath |
| Novo Nordisk INC | $73.91 | 2024-2025 | Ozempic, Rybelsus |
| Ardelyx, INC. | $53.06 | 2024-2025 | Ibsrela |
| Amgen INC. | $45.74 | 2025 | Tavneos |
| Mallinckrodt Hospital Products INC. | $31.81 | 2024 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.26 | 2024 | Jardiance |
| Apellis Pharmaceuticals, INC. | $26.01 | 2025 | Empaveli |
| Otsuka America Pharmaceutical, INC. | $23.54 | 2025 | Jynarque |
| Bayer Healthcare Pharmaceuticals INC. | $22.00 | 2025 | |
| Alexion Pharmaceuticals, INC. | $21.70 | 2025 | Ultomiris |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $21.18 | 2024 | |
| Vifor Pharma, INC. | $19.92 | 2024 | Veltassa |
| Astrazeneca Pharmaceuticals LP | $19.45 | 2024 | Farxiga |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $17.39 | 2024 | Onpattro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Brewer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.